U.S. markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.81%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • GBP/USD

    1.3922
    -0.0091 (-0.65%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.30%)
     
  • BTC-USD

    47,299.10
    -250.02 (-0.53%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

Cramer Advises Viewers On Autodesk, Inseego And More

  • Oops!
    Something went wrong.
    Please try again later.
Craig Jones
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

On CNBC's "Mad Money Lightning Round," Jim Cramer said Autodesk, Inc. (NASDAQ: ADSK) is one of the best run companies in the world. He thinks it's a buy.

Inseego Corp (NASDAQ: INSG) is terrific, said Cramer. He likes Marvell Technology Group Ltd. (NASDAQ: MRVL).

Instead of Bigcommerce Holdings, Inc. (NASDAQ: BIGC), Cramer would buy Adobe Inc (NASDAQ: ADBE).

Cramer's charitable trust owns Crown Castle International Corp (NYSE: CCI). He thinks it's in the grip of the real estate investment trust ETFs and he expects to make a giant amount of money with this stock.

Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) has a drug that is help against Alzheimer's disease, said Cramer. He almost wishes it didn't because that has proven to be an impossible disease. Biohaven's migraines drug Nurtec is the best in the show, added Cramer.

Cramer prefers Draftkings Inc (NASDAQ: DKNG) over Golden Nugget Online Gaming Inc (NASDAQ: GNOG).

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.